#NACFC2021 – Trikafta Lowers Need for Antibiotics, Mucus Clearance in Children

#NACFC2021 – Trikafta Lowers Need for Antibiotics, Mucus Clearance in Children

311424

#NACFC2021 – Trikafta Lowers Need for Antibiotics, Mucus Clearance in Children

Treatment with Trikafta lowered the need for antibiotics and mucus-clearing therapies among children and adolescents with cystic fibrosis being followed at a pediatric CF center in Utah.  Jeffery T. Zobell, a clinical pharmacist at Primary Children’s CF Center in Salt Lake City, shared the findings in the presentation “Beyond PFTs: Elexacaftor/tezacaftor/ivacaftor outcomes in a pediatric CF center,” at this year’s North American Cystic Fibrosis Conference (NACFC).  Trikafta is an oral combination of three CFTR modulators (elexacaftor,…

You must be logged in to read/download the full post.